Gould Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-407
Closed -$209K 155
2022
Q4
$209K Buy
+407
New +$207K 0.06% 145

Other funds holding ELV

Gould Asset Management's ELV Position: Q1 2023 in Review

Gould Asset Management sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 407 shares — an estimated $209K sold.

Gould Asset Management first reported a position in ELV in Q4 2022 and held it in 1 quarter. The position peaked at $209K in Q4 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • Gould Asset Management reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • Gould Asset Management sold 407 Elevance Health shares in Q1 2023, an estimated $209K.
  • Gould Asset Management first reported a position in Elevance Health in Q4 2022 and held it in 1 quarter.
  • Gould Asset Management's Elevance Health position peaked at $209K in Q4 2022.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Gould Asset Management's 13F filing for Q1 2023, filed 2 May 2023.